TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22018594 — Predictive Biomarker (PRD): VEGFC mRNA
Genes: VEGFC
Study 22018594 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 22018594 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 15522938 — Surrogate Endpoint (SUR): Serum calcium
Study 15522938 — Surrogate Endpoint (SUR): Bone mineral density
Study 2403058 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2403058 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12671188 — Surrogate Endpoint (SUR): Blood pressure
Study 12671188 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10867388 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study 26604159 — Surrogate Endpoint (SUR): Blood pressure
Study 25740794 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20156979 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15640478 — Surrogate Endpoint (SUR): Bone mineral density
Study 12360174 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 28967710 — Surrogate Endpoint (SUR): Blood pressure
Study 28967710 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31434782 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31434782 — Predictive Biomarker (PRD): KIFBP mRNA
Genes: KIFBP; KBP; KIAA1279; KIF1BP
Study 28158982 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 28158982 — Surrogate Endpoint (SUR): Blood pressure
Study 19802806 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20653455 — Surrogate Endpoint (SUR): Blood pressure
Study 18422825 — Surrogate Endpoint (SUR): Blood pressure
Study 12677265 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 9541997 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study 25625938 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31750598 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1722692 — Surrogate Endpoint (SUR): Blood pressure
Study 6460717 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 28994033 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study 22545079 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7855203 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study 7855203 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 31984514 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25694417 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25694417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 23107074 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 20128352 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27462009 — Surrogate Endpoint (SUR): Bone mineral density
Study 9255000 — Predictive Biomarker (PRD): CPZ mRNA
Genes: CPZ
Study 30121128 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30012390 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 23846165 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 3308388 — Safety Biomarker (SAF): L-acetylcarnitine
Study 26299227 — Surrogate Endpoint (SUR): Blood pressure
Study 24565713 — Surrogate Endpoint (SUR): Bone mineral density
Study 22005283 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 22005283 — Safety Biomarker (SAF): BDNF
Study 14514498 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 14514498 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 23444090 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 23444090 — Predictive Biomarker (PRD): SRGN mRNA
Genes: SRGN; PRG; PRG1
Study 11694786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 9918451 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 29461420 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 17722821 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 28460083 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21379582 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 8383904 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 31063434 — Surrogate Endpoint (SUR): Blood pressure
Study 18528405 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18528405 — Surrogate Endpoint (SUR): Blood pressure
Study 1561474 — Surrogate Endpoint (SUR): Blood pressure
Study 3886303 — Surrogate Endpoint (SUR): Blood pressure
Study 30527259 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30527259 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30527259 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17881928 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 12020982 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 27098193 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 24228531 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11229183 — Surrogate Endpoint (SUR): Serum creatinine
Study 31121104 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 17663105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8923355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8923355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1455983 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 6697306 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 28664388 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 28664388 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 23167783 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 23167783 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 10732883 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29512827 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 24606070 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 20354566 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7974906 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 28342911 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 28342911 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 28342911 — Predictive Biomarker (PRD): FCER1A mRNA
Genes: FCER1A; FCE1A
Study 28342911 — Predictive Biomarker (PRD): CPA3 mRNA
Genes: CPA3
Study 28342911 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study 28342911 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 17643436 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study 9657355 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 6119939 — Surrogate Endpoint (SUR): Blood pressure
Study 31135084 — Monitoring Biomarker (MOI): HBV DNA
Study 26371360 — Surrogate Endpoint (SUR): Blood pressure
Study 23404948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23404948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23404948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17968815 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 15156430 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12168960 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 2119153 — Surrogate Endpoint (SUR): Blood pressure
Study 710268 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 16679275 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 26730569 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25298577 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25298577 — Surrogate Endpoint (SUR): Blood pressure
Study 22001689 — Surrogate Endpoint (SUR): Blood pressure
Study 17268258 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 16136947 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 16136947 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24468886 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 16617852 — Surrogate Endpoint (SUR): Blood pressure
Study 16617852 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1318083 — Surrogate Endpoint (SUR): Blood pressure
Study 29902299 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29902299 — Predictive Biomarker (PRD): PRRG2 mRNA
Genes: PRRG2; PRGP2; TMG2
Study 26179185 — Surrogate Endpoint (SUR): Blood pressure
Study 25180479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25180479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25180479 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 25180479 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 31786983 — Surrogate Endpoint (SUR): Blood pressure
Study 21525252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21525252 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 21525252 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 11327200 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 9387134 — Surrogate Endpoint (SUR): Blood pressure
Study 24298767 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 22649136 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 19787180 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8027221 — Surrogate Endpoint (SUR): Serum calcium
Study 24399727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24399727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24399727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24399727 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 21272195 — Surrogate Endpoint (SUR): Blood pressure
Study 12648031 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1550667 — Surrogate Endpoint (SUR): Blood pressure
Study 17888803 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 30922751 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21330911 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28747269 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 28747269 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 2658875 — Surrogate Endpoint (SUR): Serum calcium
Study 2658875 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28264826 — Predictive Biomarker (PRD): HINT2 mRNA
Genes: HINT2
Study 28264826 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 23206182 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 23206182 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 23206182 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 23206182 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study 16572592 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28447237 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 21881066 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21881066 — Surrogate Endpoint (SUR): Bone mineral density
Study 19118720 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25530675 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 25530675 — Predictive Biomarker (PRD): CGAS mRNA
Genes: CGAS; C6orf150; MB21D1
Study 25530675 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 31564057 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 31564057 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 29483085 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29483085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 29483085 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 27759648 — Safety Biomarker (SAF): Reactive oxygen species
Study 25099941 — Predictive Biomarker (PRD): TBC1D4 mRNA
Genes: TBC1D4; AS160; KIAA0603
Study 12831415 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12831415 — Surrogate Endpoint (SUR): Blood pressure
Study 2864738 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 27197523 — Predictive Biomarker (PRD): Hormone receptor
Study 27197523 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24344049 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 22743029 — Predictive Biomarker (PRD): SP9 mRNA
Genes: SP9
Study 16136052 — Predictive Biomarker (PRD): Hormone receptor
Study 2140838 — Surrogate Endpoint (SUR): Blood pressure
Study 26362110 — Safety Biomarker (SAF): Hyaluronic acid
Study 8678535 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 26811166 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26811166 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26811166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24820104 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study 24820104 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10450301 — Surrogate Endpoint (SUR): Blood pressure
Study 27484097 — Predictive Biomarker (PRD): CHST15 mRNA
Genes: CHST15; BRAG; GALNAC4S6ST; KIAA0598
Study 20146880 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 11289473 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31465401 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 28557555 — Surrogate Endpoint (SUR): Blood pressure
Study 23140546 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22392497 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22392497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8535640 — Predictive Biomarker (PRD): ASPRV1 mRNA
Genes: ASPRV1; SASP
Study 11483335 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22035851 — Surrogate Endpoint (SUR): Forced vital capacity
Study 16904960 — Surrogate Endpoint (SUR): Bone mineral density
Study 9869174 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 18635671 — Predictive Biomarker (PRD): EIF2AK2 mRNA
Genes: EIF2AK2; PKR; PRKR
Study 29032666 — Surrogate Endpoint (SUR): Blood pressure
Study 9625844 — Safety Biomarker (SAF): MTHFR
Study 19766503 — Surrogate Endpoint (SUR): Blood pressure
Study 12404674 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1982576 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 6121138 — Surrogate Endpoint (SUR): Blood pressure
Study 23709097 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 10207925 — Predictive Biomarker (PRD): FURIN mRNA
Genes: FURIN; FUR; PACE; PCSK3
Study 22020607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1972963 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study 1972963 — Surrogate Endpoint (SUR): Blood pressure
Study 1972963 — Surrogate Endpoint (SUR): Serum triglycerides
Study 1972963 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27461773 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 19278583 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 19278583 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19278583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19278583 — Safety Biomarker (SAF): Human leucocyte antigen
Study 19278583 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11480461 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 11480461 — Surrogate Endpoint (SUR): Blood pressure
Study 24708031 — Surrogate Endpoint (SUR): Forced vital capacity
Study 20518086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20518086 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20518086 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 8458192 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 31177885 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11224966 — Surrogate Endpoint (SUR): Blood pressure
Study 19621718 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 16439428 — Safety Biomarker (SAF): Reactive oxygen species
Study 16439428 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9266781 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2851654 — Surrogate Endpoint (SUR): Blood pressure
Study 11932272 — Surrogate Endpoint (SUR): Bone mineral density
Study 22496329 — Predictive Biomarker (PRD): PTGDR2 mRNA
Genes: PTGDR2; CRTH2; DL1R; GPR44
Study 22496329 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 21600524 — Surrogate Endpoint (SUR): Blood pressure
Study 21600524 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21600524 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8198936 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8198936 — Surrogate Endpoint (SUR): Blood pressure
Study 11036451 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30318332 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 24503679 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 16940468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9920085 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 21178181 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 14986114 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 14986114 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 29231500 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29231500 — Surrogate Endpoint (SUR): Serum testosterone
Study 18071677 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 10510985 — Surrogate Endpoint (SUR): Blood pressure
Study 8573755 — Surrogate Endpoint (SUR): Blood pressure
Study 2232966 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27483393 — Surrogate Endpoint (SUR): Serum creatinine
Study 11432886 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9738515 — Surrogate Endpoint (SUR): Bone mineral density
Study 7527107 — Surrogate Endpoint (SUR): Blood pressure
Study 27511058 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 27511058 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 23338815 — Surrogate Endpoint (SUR): Bone mineral density
Study 15530259 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 24353564 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24353564 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24353564 — Surrogate Endpoint (SUR): Blood pressure
Study 9797850 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 9797850 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 2732449 — Monitoring Biomarker (MOI): HBV DNA
Study 16098300 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11104295 — Surrogate Endpoint (SUR): Blood pressure
Study 1455381 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 26818974 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 22883485 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22883485 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 22883485 — Safety Biomarker (SAF): Urinary total protein
Study 17894540 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 11744653 — Surrogate Endpoint (SUR): Serum testosterone
Study 29061504 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29061504 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 29061504 — Predictive Biomarker (PRD): ADAMTS1 mRNA
Genes: ADAMTS1; KIAA1346; METH1
Study 29061504 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 29061504 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 29061504 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 29061504 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 29061504 — Predictive Biomarker (PRD): CAVIN1 mRNA
Genes: CAVIN1; PTRF; FKSG13
Study 23235716 — Surrogate Endpoint (SUR): Blood pressure
Study 9196609 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 20464817 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0